Expert Opinion on Biological Therapy is a monthly peer-reviewed medical journal covering research on all aspects of biological therapy, including gene therapy and gene transfer technologies, therapeutic peptides and proteins, vaccines and antibodies, and cell- and tissue-based therapies. The journal is published by Taylor & Francis and the editor-in-chief is Michael Morse (Duke University Hospital). The journal was established in 2001 and according to the Journal Citation Reports, it has a 2014 impact factor of 3.743.[1] The journal is also indexed in MEDLINE.
| Discipline | Therapeutics |
|---|---|
| Language | English |
| Edited by | Michael Morse |
| Publication details | |
| History | 2001-present |
| Publisher | |
| Frequency | Monthly |
| 3.743 (2014) | |
| Standard abbreviations | |
| ISO 4 | Expert Opin. Biol. Ther. |
| Indexing | |
| ISSN | 1471-2598 (print) 1744-7682 (web) |
| LCCN | 2001243388 |
| OCLC no. | 48476209 |
| Links | |
This journal ranks #28 of 144 in the Biotechnology & Applied Microbiology category. In 2008 it was ranked #16 of 82 in the Medicine, Research & Experimental in ISI Journal Citation Reports.
References
- ^ "Expert Opinion on Biological Therapy". 2014 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2015.
{{cite book}}: CS1 maint: postscript (link)